Compared to Estimates, Surgery Partners (SGRY) Q2 Earnings: A Look at Key Metrics
For the quarter ended June 2023, Surgery Partners (SGRY) reported revenue of $667.6 million, up 8.5% over the same period last year. EPS came in at $0.28, compared to -$0.03 in the year-ago quarter.
The reported revenue represents a surprise of -0.05% over the Zacks Consensus Estimate of $667.94 million. With the consensus EPS estimate being $0.07, the EPS surprise was +300.00%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Surgery Partners performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Cases: 155185 versus the two-analyst average estimate of 154245.
Number of consolidated surgical facilities as of the end of period: 119 versus the two-analyst average estimate of 118.5.
Revenue per case: $4,302 compared to the $4,283.84 average estimate based on two analysts.
Number of surgical facilities as of the end of period: 152 compared to the 145.5 average estimate based on two analysts.
View all Key Company Metrics for Surgery Partners here>>>
Shares of Surgery Partners have returned -11.5% over the past month versus the Zacks S&P 500 composite's +3.3% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Surgery Partners, Inc. (SGRY) : Free Stock Analysis Report
